Literature DB >> 3857381

Combination heparin plus cortisone treatment of two transplanted tumors in C3H/He mice.

M Penhaligon, R S Camplejohn.   

Abstract

C3H/He inbred mice bearing either C3H mouse mammary or RIF-1 tumors of 180-mm3 volume were treated with a combination of heparin (500 anticoagulation U/ml drinking water) plus cortisone (either 250 mg/kg/day tapering to 37 mg/kg/day or a constant dose of 75 mg/kg/day). Five types of heparin were tested in this study. RIF-1 tumors shrank to approximately half the volume at the start of therapy after only 3 days of treatment; mammary tumors took longer to respond, not reaching half the starting volume until after 11 days of treatment. In both tumors response was transient, the tumors eventually regrowing. However, response to combined heparin and cortisone therapy was in fact no different from the response to cortisone used alone. Also, cortisone treatment was extremely toxic to these animals and experiments had to be terminated after about 3 weeks of therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3857381

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  10 in total

1.  Multi-parametric assessment of the anti-angiogenic effects of liposomal glucocorticoids.

Authors:  Ewelina Kluza; Marieke Heisen; Sophie Schmid; Daisy W J van der Schaft; Raymond M Schiffelers; Gert Storm; Bart M ter Haar Romeny; Gustav J Strijkers; Klaas Nicolay
Journal:  Angiogenesis       Date:  2011-01-12       Impact factor: 9.596

2.  Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.

Authors:  Raymond M Schiffelers; Josbert M Metselaar; Marcel H A M Fens; Adriënne P C A Janssen; Grietje Molema; Gert Storm
Journal:  Neoplasia       Date:  2005-02       Impact factor: 5.715

3.  Cortisone inhibition of tumor angiogenesis measured by a quantitative colorimetric assay in mice.

Authors:  K E Lee; M Iwamura; A T Cockett
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate.

Authors:  R J Tamargo; K W Leong; H Brem
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

5.  Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants.

Authors:  Y Hori; D E Hu; K Yasui; R L Smither; G A Gresham; T P Fan
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

6.  beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.

Authors:  B A Teicher; E A Sotomayor; Z D Huang; G Ara; S Holden; V Khandekar; Y N Chen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.

Authors:  E A Sotomayor; B A Teicher; G N Schwartz; S A Holden; K Menon; T S Herman; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: a regional antiangiogenic therapy.

Authors:  Y Arisawa; E Sutanto-Ward; L Fortunato; E R Sigurdson
Journal:  Ann Surg Oncol       Date:  1995-03       Impact factor: 5.344

9.  Treatment with cortisone plus heparin or hexuronyl hexoaminoglycan sulfates of murine tumors and their lung deposits.

Authors:  L Milas; N Hunter; I Basic
Journal:  Clin Exp Metastasis       Date:  1985 Oct-Dec       Impact factor: 5.150

10.  Inhibition of angiogenesis and murine tumour growth by laminarin sulphate.

Authors:  R Hoffman; D H Paper; J Donaldson; H Vogl
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.